Shannon Marie Goblirsch, PHARM.D.,R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39648 Reservation Highway 3, Morton, MN 56270 Phone: 507-697-8950 Fax: 507-697-8954 |
News Archive
A new clinical trial published today in Obesity Research (the journal of NAASO, the Obesity Society) provides more insight into why consuming dairy foods is linked to weight and fat loss.
New findings show unexplained weight loss that precedes dementia by more than 10 years is associated with the severity of Alzheimer changes in the brain.
Cell Therapeutics, Inc. ("CTI") announced today that it has applied to the European Medicines Agency (EMEA) for orphan drug designation for pixantrone. CTI initiated the process of obtaining marketing approval in Europe in July, 2009, for the treatment of relapsed or refractory aggressive NHL.
The health insurer WellPoint has announced guidelines for using comparative effectiveness studies to pit drugs against one another and determine which works best, the Indianapolis Business Journal reports. "Congress has also approved $4.1 billion in the past 15 months to fund comparative-effectiveness studies and a new agency that specializes in them.
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in the New England Journal of Medicine and presented at the 2020 American Society of Clinical Oncology Annual Meeting ASCO20 Virtual Meeting (Abstract 9556 - Poster 322) by researchers from The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago